Related Experiment Video

Updated: May 5, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

7.1K

Raised plasma concentrations of platelet factor 4 (PF4) in Crohn's disease

M Simi, S Leardi, M T Tebano

    Gut
    |March 1, 1987
    PubMed

    Insights

    Platelet factor 4 (PF4) is significantly elevated in Crohn's disease patients, indicating increased platelet aggregation and thromboembolic risk. This finding was consistent regardless of disease activity or treatment.

    Area of Science:

    • Gastroenterology
    • Hematology
    • Immunology

    Background:

    • Plasma platelet factor 4 (PF4) is a marker for platelet activation and thromboembolic risk.
    • Crohn's disease is a chronic inflammatory bowel disease with potential thrombotic complications.

    Purpose of the Study:

    • To investigate plasma PF4 levels in patients with Crohn's disease.
    • To determine if PF4 concentration correlates with disease activity, location, or treatment.

    Main Methods:

    • Radioimmunoassay was used to measure PF4 concentrations in plasma samples.
    • The study included 20 Crohn's disease patients and 20 healthy controls.

    Main Results:

    • Crohn's disease patients exhibited significantly higher PF4 levels (4.625 +/- 1.1 nmol/ml) compared to controls (0.189 +/- 0.07 nmol/ml).
    • PF4 levels did not correlate with disease activity (Crohn's Disease Activity Index < 150), disease site (ileitis vs. ileocolitis), or medical treatment (including prednisone).

    Conclusions:

    • Elevated plasma PF4 is a potential biomarker for increased platelet aggregation in Crohn's disease.
    • PF4 levels do not appear to be influenced by disease severity or treatment in this cohort.

    More Related Videos

    Microfluidics in Assessing Platelet Function06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    1.7K
    Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets10:08

    Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

    Published on: November 22, 2024

    1.8K

    Related Concept Videos

    Structure and Function of Platelets01:18

    Structure and Function of Platelets

    The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
    Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
    7.2K
    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

    Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
    897
    Inflammatory Bowel Disease II: Crohn's Disease01:30

    Inflammatory Bowel Disease II: Crohn's Disease

    Introduction
    Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
    Crohn's disease
    Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
    1.6K
    Inflammatory Bowel Disease II: Ulcerative Colitis01:20

    Inflammatory Bowel Disease II: Ulcerative Colitis

    Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
    57
    Inflammatory Bowel Disease III: Crohn's Disease01:25

    Inflammatory Bowel Disease III: Crohn's Disease

    Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
    69
    Inflammatory Bowel Disease IV: Clinical Manifestations01:20

    Inflammatory Bowel Disease IV: Clinical Manifestations

    Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
    64